Prosecution Insights
Last updated: October 04, 2026

Newleaf Symbiotics Inc.

Technology area: Biotechnology & Pharmaceuticals

5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Analysis

Newleaf Symbiotics Inc. has 5 pending office actions currently active in the Biotechnology & Pharmaceuticals technology area. These 5 actions are being handled by a matching number of distinct examiners, which indicates a broad distribution of the company's prosecution efforts. This variety of examiners means that the company's legal team must address different sets of examiner feedback and preferences across its pending applications.

The portfolio is spread across 3 distinct art units, showing that the company's biological innovations fall under the jurisdiction of several different specialized groups. The busiest examiner, FAN, WEIHUA, is currently assigned 1 pending office action. With each of the pending actions assigned to a different examiner, the portfolio lacks any single point of concentration. This structure suggests that the company's success in the Biotechnology & Pharmaceuticals sector is subject to the independent reviews of different officials across the 3 separate art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
2
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (40%)
1
Medium (20%)
1
Easy (20%)
1
Unknown (20%)

Rejection Statute Mix

BucketCases
§103 only1 (20%)
§112 only1 (20%)
Multi-statute (no §101)2 (40%)
No statute on record1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FAN, WEIHUA 1 83.4% +12.6%
DICKENS, AMELIA NICOLE 1 47.6% +21.1%
SCOTLAND, REBECCA LYNN 1 0.0% +0.0%
LYONS, MARY M 1 65.5% +41.5%
PURDY, KYLE A 1 41.0% +35.9%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17255270 SELECTION AND GENETIC MODIFICATION OF PLANT ASSOCIATED METHYLOBACTERIUM LYONS, MARY M 30d overdue
18004937 MICROBIAL INOCULANT FORMULATIONS SCOTLAND, REBECCA LYNN 28d

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17255270 SELECTION AND GENETIC MODIFICATION OF PLANT ASSOCIATED METHYLOBACTERIUM LYONS, MARY M 30d overdue
17056797 MICROBIAL MICROCAPSULE COMPOSITIONS, METHODS AND RELATED METHODS PURDY, KYLE A 18d overdue
19299056 METHODS AND COMPOSITIONS FOR CONTROLLING ROOT LESION NEMATODES FAN, WEIHUA —
18488471 METHYLOBACTERIUM STRAINS FOR CONTROLLING CORN ROOTWORM DICKENS, AMELIA NICOLE —

Top Art Units

Art UnitApps
1645 2
1615 1
1611 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19299056 METHODS AND COMPOSITIONS FOR CONTROLLING ROOT LESION NEMATODES FAN, WEIHUA — Other Non-Final OA — Pending Aug 13, 2025
18488471 METHYLOBACTERIUM STRAINS FOR CONTROLLING CORN ROOTWORM DICKENS, AMELIA NICOLE 1645 §112 Final Rejection — Pending Oct 17, 2023
18004937 MICROBIAL INOCULANT FORMULATIONS SCOTLAND, REBECCA LYNN 1615 §103§112 Final Rejection 28d Pending Jan 10, 2023
17255270 SELECTION AND GENETIC MODIFICATION OF PLANT ASSOCIATED METHYLOBACTERIUM LYONS, MARY M 1645 §102§103 Final Rejection 30d overdue Pending Dec 22, 2020
17056797 MICROBIAL MICROCAPSULE COMPOSITIONS, METHODS AND RELATED METHODS PURDY, KYLE A 1611 §103 Non-Final OA 18d overdue Pending Nov 19, 2020

Managing Newleaf Symbiotics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month